<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05106075</url>
  </required_header>
  <id_info>
    <org_study_id>2020/562</org_study_id>
    <nct_id>NCT05106075</nct_id>
  </id_info>
  <brief_title>Pilot Study to Validate ex Vivo Expression of Specific Biomarkers of Human Resolutive Macrophages</brief_title>
  <acronym>RESOMACRO</acronym>
  <official_title>Pilot Study to Validate ex Vivo Expression of Specific Biomarkers of Human Resolutive Macrophages</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Human resolutive macrophages are essential immune cells in the resolution of inflammation.&#xD;
      This particular type of macrophages remains poorly known and currently there are no&#xD;
      biomarkers to identify them in vivo. Within UMR1098-RIGHT, specific biomarkers (secreted&#xD;
      molecules and membrane receptors) of human resolutive macrophages (healthy volunteers) have&#xD;
      been identified in vitro, but their existence in vivo remains an outstanding issue. An&#xD;
      exploratory study (lack of data from the literature) will validate the ex vivo expression of&#xD;
      these markers in samples of patients whose inflammation is not, or little, supported by the&#xD;
      available therapies (NSAIDs, biotherapies, corticosteroids).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 7, 2021</start_date>
  <completion_date type="Anticipated">January 7, 2024</completion_date>
  <primary_completion_date type="Anticipated">January 7, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>patients are anonymized</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Quantification of cytokine concentrations in samples by ELISA</measure>
    <time_frame>up to 2 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>biologic sample collection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Blood samples or gingival exsudat collection</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>blood sample or joint fluid or gingival exudate</intervention_name>
    <description>blood sample collected by peripheral blood mobilization joint fluid collected by punction gingival exudate collected with paper strips</description>
    <arm_group_label>biologic sample collection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age Limits (18-80 years)&#xD;
&#xD;
          -  Information and non-opposition for participating in the study&#xD;
&#xD;
          -  Patients suffering from periodontitis grade III ou IV&#xD;
&#xD;
          -  Patients suffering from microcristalline arthritis&#xD;
&#xD;
          -  patient with health insurance&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patient under corticotherapy&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  non-compliant patient&#xD;
&#xD;
          -  patient with no health insurance&#xD;
&#xD;
          -  patient in exclusion period from an other study&#xD;
&#xD;
          -  legal incapacity&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Thomas CHERRIER, MCU-PH</last_name>
    <phone>+33(0)768207057</phone>
    <email>tcherrier@unistra.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHRU Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Wendling</last_name>
    </contact>
    <investigator>
      <last_name>Daniel Wendling</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dentist'S Office</name>
      <address>
        <city>Montbéliard</city>
        <zip>25200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laure Tisserand</last_name>
    </contact>
    <investigator>
      <last_name>Laure Tisserand</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 8, 2021</study_first_submitted>
  <study_first_submitted_qc>October 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 3, 2021</study_first_posted>
  <last_update_submitted>October 25, 2021</last_update_submitted>
  <last_update_submitted_qc>October 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>macrophage</keyword>
  <keyword>inflammation</keyword>
  <keyword>inflammation resolution</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

